SCM

Sarissa Capital Management Portfolio holdings

AUM $154M
This Quarter Return
+12.33%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$514M
AUM Growth
+$514M
Cap. Flow
+$87.7M
Cap. Flow %
17.06%
Top 10 Hldgs %
96.45%
Holding
21
New
2
Increased
3
Reduced
1
Closed
4
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BIIB icon
1
Biogen
BIIB
$19.4B
$95M 18.46% +310,000 New +$95M
ABBV icon
2
AbbVie
ABBV
$372B
$93.6M 18.2% 1,580,000
ARIA
3
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$80.3M 15.61% 12,850,000
MDCO
4
DELISTED
Medicines Co
MDCO
$58.5M 11.38% 1,567,000
DGX icon
5
Quest Diagnostics
DGX
$20.3B
$40.9M 7.95% 575,000
PCRX icon
6
Pacira BioSciences
PCRX
$1.2B
$40.9M 7.95% 532,200 +152,200 +40% +$11.7M
ITCI
7
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$36.3M 7.06% 675,000 +35,000 +5% +$1.88M
AEGR
8
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
$26.1M 5.07% 2,580,000 +25,000 +1% +$253K
AMGN icon
9
Amgen
AMGN
$155B
$14.6M 2.84% 90,000
ESPR icon
10
Esperion Therapeutics
ESPR
$448M
$9.97M 1.94% 448,000
SEEL
11
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$6.46M 1.26% 6,524,505
ARRY
12
DELISTED
Array Biopharma Inc
ARRY
$2.95M 0.57% +700,000 New +$2.95M
AVEO
13
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.92M 0.57% 2,313,759
VVUS
14
DELISTED
Vivus Inc
VVUS
$2.63M 0.51% 2,573,943
ANIP icon
15
ANI Pharmaceuticals
ANIP
$2.03B
$1.4M 0.27% 31,000
RPRX
16
DELISTED
Repros Therapeutics Inc.
RPRX
$1.21M 0.24% 1,001,000 -131,367 -12% -$159K
CARM icon
17
Carisma Therapeutics
CARM
$8.98M
-41,200 Closed -$99K
GYRE icon
18
Gyre Therapeutics
GYRE
$703M
-90,000 Closed -$419K
MRK icon
19
Merck
MRK
$210B
-400,000 Closed -$19.8M
KIN
20
DELISTED
Kindred Biosciences, Inc.
KIN
-689,091 Closed -$3.58M